Loading candles…
Sai Parenterals Ltd., incorporated in 2001 and headquartered in Hyderabad, India, operates within the pharmaceutical industry. The company focuses on the research, development, manufacturing, and supply of pharmaceutical formulations with a specialization in parenteral products, including sterile injectables and large-volume parenterals. Its business segments encompass pharmaceutical formulations, parenteral products, and large-volume parenterals. Sai Parenterals serves the Indian market and is publicly listed on Indian stock exchanges, having completed its listing in April 2026. No subsidiaries, founders, or key management details have been disclosed.
This page is a live market overview for SAI PARENTERALS LIMITED (SAIPARENT) on the NSE. As a listed security, SAI PARENTERALS LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SAIPARENT before placing trades on tick2trade.
As of the latest feed, SAIPARENT last traded at ₹569.7 on NSE, up ₹28.55 (5.28%) from the previous close of ₹541.15. Today's session range is ₹535.55 – ₹580, against a 52-week band of ₹400 – ₹706. Traded volume today stands at 2.66L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for SAIPARENT in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SAIPARENT is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SAI PARENTERALS LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SAIPARENT. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SAIPARENT option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 11 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 23 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 23 May 2026 |
| Other | To consider other business matters | 20 Apr 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.